衰老过程中脑血管活性反应调节的变化:H2S在cgmp诱导的舒张中的作用

IF 0.5 Q4 GERIATRICS & GERONTOLOGY
O. P. Gorshkova, V. N. Shuvaeva
{"title":"衰老过程中脑血管活性反应调节的变化:H2S在cgmp诱导的舒张中的作用","authors":"O. P. Gorshkova,&nbsp;V. N. Shuvaeva","doi":"10.1134/S207905702560034X","DOIUrl":null,"url":null,"abstract":"<p>The signaling cascade “NO → soluble guanylate cyclase (sGC) → cyclic guanosine monophosphate (cGMP) → protein kinase G (PKG)” plays a significant role in vascular dilation, and its dysfunction can cause the development of cerebrovascular diseases. The key element in the NO → PKG signaling system is cGMP. Intracellular cGMP levels are largely regulated by cGMP-hydrolyzing phosphodiesterase (PDE) enzymes that break down cGMP. Aging is accompanied by a decrease in NO synthesis and cGMP levels and an increase in PDE activity. Under these conditions, it is possible to increase the contribution of compensatory mechanisms of the activation of individual sections of the NO → PKG signaling pathway, in particular with the participation of intermediaries that change the cGMP level. Hydrogen sulfide (H<sub>2</sub>S) is currently considered one of the activators of the NO → PKG pathway, which can increase cGMP levels in cells by inhibiting PDE or its direct interaction with cGMP to form biologically active compounds that are less susceptible to enzymatic breakdown. H<sub>2</sub>S-mediated cGMP activation has been shown in cardiomyocytes and smooth muscle cells of the mesenteric and aortic vessels, but this mechanism has not been studied in cerebral vessels. The aim of the work is to study the contribution of H<sub>2</sub>S to the regulation of cGMP-induced vasodilation in cerebral vessels and how this mechanism of regulation changes with aging. In Sprague-Dawley 4 (young) and 18-month-old (aging) rats, a comparative study of the dilatation of pial arteries to the effect of 8-Br-cGMP (8-bromine-cyclic guanosine monophosphate), which is a cell-permeable analog of cGMP, is performed using intravital microphotography, and an assessment of the effect of exogenous (donor is NaHS) and endogenous H<sub>2</sub>S on the cGMP-induced vasodilation is carried out. Propargylglycine is used as a blocker of endogenous H<sub>2</sub>S. It is shown that in 4-month-old rats, the H<sub>2</sub>S-mediated regulation of cGMP-induced dilation of pial arteries is expressed only at the level of large arteries with a diameter of more than 40 μm. Aging leads to an increased contribution of endogenous H<sub>2</sub>S to the cGMP-induced dilation of pial arteries of all calibers and an increased sensitivity of cGMP-mediated reactions of small pial arteries to exogenous H<sub>2</sub>S.</p>","PeriodicalId":44756,"journal":{"name":"Advances in Gerontology","volume":"15 2","pages":"64 - 70"},"PeriodicalIF":0.5000,"publicationDate":"2025-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Changes in the Regulation of Cerebral Vasoactive Reactions in Aging: The Contribution of H2S to cGMP-Induced Dilation\",\"authors\":\"O. P. Gorshkova,&nbsp;V. N. Shuvaeva\",\"doi\":\"10.1134/S207905702560034X\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>The signaling cascade “NO → soluble guanylate cyclase (sGC) → cyclic guanosine monophosphate (cGMP) → protein kinase G (PKG)” plays a significant role in vascular dilation, and its dysfunction can cause the development of cerebrovascular diseases. The key element in the NO → PKG signaling system is cGMP. Intracellular cGMP levels are largely regulated by cGMP-hydrolyzing phosphodiesterase (PDE) enzymes that break down cGMP. Aging is accompanied by a decrease in NO synthesis and cGMP levels and an increase in PDE activity. Under these conditions, it is possible to increase the contribution of compensatory mechanisms of the activation of individual sections of the NO → PKG signaling pathway, in particular with the participation of intermediaries that change the cGMP level. Hydrogen sulfide (H<sub>2</sub>S) is currently considered one of the activators of the NO → PKG pathway, which can increase cGMP levels in cells by inhibiting PDE or its direct interaction with cGMP to form biologically active compounds that are less susceptible to enzymatic breakdown. H<sub>2</sub>S-mediated cGMP activation has been shown in cardiomyocytes and smooth muscle cells of the mesenteric and aortic vessels, but this mechanism has not been studied in cerebral vessels. The aim of the work is to study the contribution of H<sub>2</sub>S to the regulation of cGMP-induced vasodilation in cerebral vessels and how this mechanism of regulation changes with aging. In Sprague-Dawley 4 (young) and 18-month-old (aging) rats, a comparative study of the dilatation of pial arteries to the effect of 8-Br-cGMP (8-bromine-cyclic guanosine monophosphate), which is a cell-permeable analog of cGMP, is performed using intravital microphotography, and an assessment of the effect of exogenous (donor is NaHS) and endogenous H<sub>2</sub>S on the cGMP-induced vasodilation is carried out. Propargylglycine is used as a blocker of endogenous H<sub>2</sub>S. It is shown that in 4-month-old rats, the H<sub>2</sub>S-mediated regulation of cGMP-induced dilation of pial arteries is expressed only at the level of large arteries with a diameter of more than 40 μm. Aging leads to an increased contribution of endogenous H<sub>2</sub>S to the cGMP-induced dilation of pial arteries of all calibers and an increased sensitivity of cGMP-mediated reactions of small pial arteries to exogenous H<sub>2</sub>S.</p>\",\"PeriodicalId\":44756,\"journal\":{\"name\":\"Advances in Gerontology\",\"volume\":\"15 2\",\"pages\":\"64 - 70\"},\"PeriodicalIF\":0.5000,\"publicationDate\":\"2025-08-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advances in Gerontology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://link.springer.com/article/10.1134/S207905702560034X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"GERIATRICS & GERONTOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Gerontology","FirstCategoryId":"1085","ListUrlMain":"https://link.springer.com/article/10.1134/S207905702560034X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

NO→可溶性鸟苷酸环化酶(sGC)→环鸟苷单磷酸(cGMP)→蛋白激酶G (PKG)信号级联在血管扩张中起重要作用,其功能障碍可导致脑血管疾病的发生。NO→PKG信号系统的关键元件是cGMP。细胞内cGMP水平主要受分解cGMP的cGMP水解磷酸二酯酶(PDE)调节。衰老伴随着NO合成和cGMP水平的下降以及PDE活性的增加。在这些条件下,有可能增加NO→PKG信号通路各个部分激活的补偿机制的贡献,特别是在改变cGMP水平的中介体的参与下。硫化氢(H2S)目前被认为是NO→PKG通路的激活剂之一,它可以通过抑制PDE或其与cGMP的直接相互作用来增加细胞中的cGMP水平,从而形成不易被酶分解的生物活性化合物。h2s介导的cGMP激活已在肠系膜血管和主动脉血管的心肌细胞和平滑肌细胞中被证实,但这一机制尚未在脑血管中得到研究。本研究旨在研究H2S对cgmp诱导的脑血管血管舒张的调节作用,以及这种调节机制如何随着年龄的增长而变化。在Sprague-Dawley 4(幼年)和18月龄(衰老)大鼠中,采用活体显微摄影技术比较了8-Br-cGMP(8-溴环鸟苷单磷酸)(cGMP的细胞渗透性类似物)对动脉扩张的影响,并评估了外源性(NaHS)和内源性H2S对cGMP诱导的血管扩张的影响。丙基甘氨酸被用作内源性H2S的阻滞剂。结果表明,在4月龄大鼠中,h2s介导的对cgmp诱导的头动脉扩张的调节仅在直径大于40 μm的大动脉水平上表达。衰老导致内源性H2S对cgmp诱导的所有口径的动脉扩张的贡献增加,以及cgmp介导的小动脉对外源性H2S反应的敏感性增加。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Changes in the Regulation of Cerebral Vasoactive Reactions in Aging: The Contribution of H2S to cGMP-Induced Dilation

Changes in the Regulation of Cerebral Vasoactive Reactions in Aging: The Contribution of H2S to cGMP-Induced Dilation

Changes in the Regulation of Cerebral Vasoactive Reactions in Aging: The Contribution of H2S to cGMP-Induced Dilation

The signaling cascade “NO → soluble guanylate cyclase (sGC) → cyclic guanosine monophosphate (cGMP) → protein kinase G (PKG)” plays a significant role in vascular dilation, and its dysfunction can cause the development of cerebrovascular diseases. The key element in the NO → PKG signaling system is cGMP. Intracellular cGMP levels are largely regulated by cGMP-hydrolyzing phosphodiesterase (PDE) enzymes that break down cGMP. Aging is accompanied by a decrease in NO synthesis and cGMP levels and an increase in PDE activity. Under these conditions, it is possible to increase the contribution of compensatory mechanisms of the activation of individual sections of the NO → PKG signaling pathway, in particular with the participation of intermediaries that change the cGMP level. Hydrogen sulfide (H2S) is currently considered one of the activators of the NO → PKG pathway, which can increase cGMP levels in cells by inhibiting PDE or its direct interaction with cGMP to form biologically active compounds that are less susceptible to enzymatic breakdown. H2S-mediated cGMP activation has been shown in cardiomyocytes and smooth muscle cells of the mesenteric and aortic vessels, but this mechanism has not been studied in cerebral vessels. The aim of the work is to study the contribution of H2S to the regulation of cGMP-induced vasodilation in cerebral vessels and how this mechanism of regulation changes with aging. In Sprague-Dawley 4 (young) and 18-month-old (aging) rats, a comparative study of the dilatation of pial arteries to the effect of 8-Br-cGMP (8-bromine-cyclic guanosine monophosphate), which is a cell-permeable analog of cGMP, is performed using intravital microphotography, and an assessment of the effect of exogenous (donor is NaHS) and endogenous H2S on the cGMP-induced vasodilation is carried out. Propargylglycine is used as a blocker of endogenous H2S. It is shown that in 4-month-old rats, the H2S-mediated regulation of cGMP-induced dilation of pial arteries is expressed only at the level of large arteries with a diameter of more than 40 μm. Aging leads to an increased contribution of endogenous H2S to the cGMP-induced dilation of pial arteries of all calibers and an increased sensitivity of cGMP-mediated reactions of small pial arteries to exogenous H2S.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Advances in Gerontology
Advances in Gerontology GERIATRICS & GERONTOLOGY-
CiteScore
0.80
自引率
16.70%
发文量
45
期刊介绍: Advances in Gerontology focuses on biomedical aspects of aging. The journal also publishes original articles and reviews on progress in the following research areas: demography of aging; molecular and physiological mechanisms of aging, clinical gerontology and geriatrics, prevention of premature aging, medicosocial aspects of gerontology, and behavior and psychology of the elderly.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信